Caputo M, Bullara V, Mele C, Samà M T, Zavattaro M, Ferrero A, Daffara T, Leone I, Giachetti G, Antoniotti V, Longo D, De Pedrini A, Marzullo P, Remorgida V, Prodam F, Aimaretti G
Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Int J Endocrinol. 2021 Dec 26;2021:9474805. doi: 10.1155/2021/9474805. eCollection 2021.
To evaluate clinical characteristics and perinatal outcomes in a heterogeneous population of Caucasians born in Italy and High Migration Pressure Countries (HMPC) women with GDM living in Piedmont, North Italy.
We retrospectively analyzed data from 586 women referring to our unit (2015-2020). Epidemiological (age and country of origin) and clinical-metabolic features (height, weight, family history of DM, parity, previous history of GDM, OGTT results, and GDM treatment) were collected. The database of certificates of care at delivery was consulted in relation to neonatal/maternal complications (rates of caesarean sections, APGAR score, fetal malformations, and neonatal anthropometry).
43.2% of women came from HMPC; they were younger ( < 0.0001) and required insulin treatment more frequently than Caucasian women born in Italy ( = 17.8, =0.007). Higher fasting and 120-minute OGTT levels and gestational BMI increased the risk of insulin treatment (OGTT T0: OR = 1.04, CI 95% 1.016-1.060, =0.005; OGTT T120: OR = 1.01, CI 95% 1.002-1.020, =0.02; BMI: OR = 1.089, CI 95% 1.051-1.129, < 0.0001). Moreover, two or more diagnostic OGTT glucose levels doubled the risk of insulin therapy (OR = 2.03, IC 95% 1.145-3.612, =0.016). We did not find any association between ethnicities and neonatal/maternal complications.
In our multiethnic GDM population, the need for intensive care and insulin treatment is high in HPMC women although the frequency of adverse peripartum and newborn outcomes does not vary among ethnic groups. The need for insulin therapy should be related to different genetic backgrounds, dietary habits, and Nutrition Transition phenomena. Thus, nutritional intervention and insulin treatment need to be tailored.
评估意大利出生的白种人和居住在意大利北部皮埃蒙特的高移民压力国家(HMPC)患有妊娠期糖尿病(GDM)的女性这一异质人群的临床特征和围产期结局。
我们回顾性分析了转诊至我们科室的586名女性(2015 - 2020年)的数据。收集了流行病学(年龄和原籍国)和临床代谢特征(身高、体重、糖尿病家族史、产次、既往GDM史、口服葡萄糖耐量试验(OGTT)结果以及GDM治疗情况)。查阅分娩护理证书数据库以获取新生儿/母亲并发症(剖宫产率、阿氏评分、胎儿畸形和新生儿人体测量学)相关信息。
43.2%的女性来自HMPC;她们比在意大利出生的白种女性更年轻(<0.0001),且比意大利出生的白种女性更频繁地需要胰岛素治疗(χ² = 17.8,P = 0.007)。更高的空腹和120分钟OGTT水平以及孕期体重指数(BMI)增加了胰岛素治疗的风险(OGTT T0:比值比(OR)= 1.04,95%置信区间(CI)1.016 - 1.060,P = 0.005;OGTT T120:OR = 1.01,95% CI 1.002 - 1.020,P = 0.02;BMI:OR = 1.089,95% CI 1.051 - 1.129,P < 0.0001)。此外,两次或更多次诊断性OGTT血糖水平使胰岛素治疗风险加倍(OR = 2.03,95%置信区间(IC)1.145 - 3.612,P = 0.016)。我们未发现种族与新生儿/母亲并发症之间存在任何关联。
在我们的多民族GDM人群中,HMPC女性对重症监护和胰岛素治疗的需求较高,尽管围产期和新生儿不良结局的发生率在不同种族之间没有差异。胰岛素治疗的需求应与不同的遗传背景、饮食习惯和营养转型现象相关。因此,营养干预和胰岛素治疗需要量身定制。